Gapping up
In reaction to strong earnings/guidance: DLNG +17%, NETE +12.9%, NLST +11.8%, AFMD +3%, SPLS +2.2%, LOW +1.1%, HRL +0.8%
M&A news: SAAS +53.9% (to be acquired by NICE (NICE) for $14.00/share in cash), ANDE +29.1% (HC2 Holdings (HCHC) sends letter to Chairman of ANDE stating desire to acquire Co for $37/share in cash; ANDE rejects two non-binding, 'highly conditional', unsolicited proposals from HC2 Holdings (HCHC)), MZOR +24.2% (Mazor Robotics enters into two strategic agreements with Medtronic plc (MDT); Medtronic to take 10% equity stake), CHD +5.3% (cont M&A speculation with PG), ARMH +2.5% (acquires Apical for $350 mln, acquisition closed on May 17), NICE +2.3% (acquiring SAAS for $14 per share)
Other news: PETX +7.4% (announces the FDA Center for Veterinary Medicine approved Entyce for appetite stimulation in dogs), AGIO +5.3% (Agios Pharma & Celgene announce a strategic collaboration focused on metabolic immuno-oncology, Agios to receive an upfront cash payment of $200 mln ), CETX +3.6% (Cemtrex files to withdraw form S-3 files with SEC on April 11, 2016 ), AVXL +2.7% (announces treatment with Anavex 2-73 'significantly' reduced number of spasms in an animal model with infantile spasms in infant rats), NOK +1.8% (announced plans that will see the Nokia brand return to the mobile phone and tablet markets on a global basis), AVID +1.5% (CEO disclosed purchase of 100K shares in multiple transactions),
Analyst comments: TSLA +2% (upgraded to Buy from Neutral at Goldman; tgt $250), PLCE +1.3% (upgraded to Buy from Neutral at Goldman)
In reaction to strong earnings/guidance: DLNG +17%, NETE +12.9%, NLST +11.8%, AFMD +3%, SPLS +2.2%, LOW +1.1%, HRL +0.8%
M&A news: SAAS +53.9% (to be acquired by NICE (NICE) for $14.00/share in cash), ANDE +29.1% (HC2 Holdings (HCHC) sends letter to Chairman of ANDE stating desire to acquire Co for $37/share in cash; ANDE rejects two non-binding, 'highly conditional', unsolicited proposals from HC2 Holdings (HCHC)), MZOR +24.2% (Mazor Robotics enters into two strategic agreements with Medtronic plc (MDT); Medtronic to take 10% equity stake), CHD +5.3% (cont M&A speculation with PG), ARMH +2.5% (acquires Apical for $350 mln, acquisition closed on May 17), NICE +2.3% (acquiring SAAS for $14 per share)
Other news: PETX +7.4% (announces the FDA Center for Veterinary Medicine approved Entyce for appetite stimulation in dogs), AGIO +5.3% (Agios Pharma & Celgene announce a strategic collaboration focused on metabolic immuno-oncology, Agios to receive an upfront cash payment of $200 mln ), CETX +3.6% (Cemtrex files to withdraw form S-3 files with SEC on April 11, 2016 ), AVXL +2.7% (announces treatment with Anavex 2-73 'significantly' reduced number of spasms in an animal model with infantile spasms in infant rats), NOK +1.8% (announced plans that will see the Nokia brand return to the mobile phone and tablet markets on a global basis), AVID +1.5% (CEO disclosed purchase of 100K shares in multiple transactions),
Analyst comments: TSLA +2% (upgraded to Buy from Neutral at Goldman; tgt $250), PLCE +1.3% (upgraded to Buy from Neutral at Goldman)